Cannabis Stocks Soar After Trump Praises CBD for Seniors’ Health
- Sep 29, 2025
- 2 min read
29 September 2025
Cannabis stocks jumped sharply in early trading on Monday, September 29, 2025, after former President Donald Trump posted on social media that cannabidiol (CBD) could “revolutionize senior healthcare,” helping slow disease progression and offering an alternative to conventional prescriptions.
Among the biggest gainers were Canopy Growth and Tilray Brands, each surging nearly 20 percent before the opening bell. Cronos Group and Aurora Cannabis also climbed, lifting sentiment across the sector. The AdvisorShares Pure U.S. Cannabis ETF (MSOS) spiked 20.6 percent, putting it on track for what could be its strongest quarterly performance ever—an estimated 70 percent gain.
Investors and analysts saw Trump’s endorsement as a potent signal. His support for classifying CBD as a healthcare tool for seniors suggests potential policy changes. Earlier in August, his administration indicated interest in reclassifying marijuana under federal law, which could ease regulatory constraints and expand clinical and commercial access.
One major barrier for cannabis companies has been Section 280E of the tax code. Under that rule, federally prohibited cannabis firms are barred from taking ordinary business deductions a significant financial burden. Reclassification could help remove that barrier and open more favorable tax and capital market conditions.
Still, uncertainty remains. While Trump’s statements injected fresh optimism, legal and regulatory questions loom. Deregulation or reclassification at the federal level would require legislative or administrative follow-through, and opposition from some lawmakers and agencies remains.
For now the market reaction underscores how sentiment and policy outlooks heavily influence the cannabis space. What began as a social media post reshaped trading patterns and put CBD reform back in the spotlight.
Comments